Recent Advances in New Copolymer Hydrogel‐Formed Contact Lenses for Ophthalmic Drug Delivery
Source abstract
Abstract
Abstract Pharmaceuticals delivery to the eye sites of interest via the means of contact lenses (CLs) has attracted significant research attention in recent years. Compared with the conventional formulation in eye treatment such as eye drops, CLs administration has shown remarkable advantages in overcoming the challenges involved in ocular drug delivery such as higher bioavailability, longer drug residence and better medication compliance. This review will first detail each of the material components which have been used in the context of CLs, including HEMA, MAA, DMA, NVP, EGDMA, TRIS and PDMS. The pros and cons of each material in tailoring drug release rates of different encapsulated payloads will be discussed, with special focus on their impact on the therapeutic efficiency. In addition, the advancement of recent emerging copolymer CLs hydrogels, originated from these sophisticated monomers with distinct functions, are further summarized into several synthetic strategies in the means of copolymer architecture design and function‐performance relationship in ophthalmic applications. Finally, the possible considerations for future design of multifunctional CLs hydrogels by combing material selection rationales with biological interface science are proposed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Corneal Surgery and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology School of Pharmaceutical Sciences Xiamen University Xiamen 361102 P. R. China
Institute of Materials Research and Engineering A*STAR (Agency for Science, Technology and Research) 2 Fusionopolis Way, Innovis, #08-03 Singapore 138634 Singapore
Funding
National Natural Science Foundation of China
References (87)
Show source-provided references
1. 10.1517/17425247.3.2.27510.1517/17425247.3.2.275 ↗
2. 10.1080/09205063.2020.171217510.1080/09205063.2020.1712175 ↗
3. 10.1039/D0RA06681H10.1039/D0RA06681H ↗
4. 10.3390/ma1202026110.3390/ma12020261 ↗
5. 10.2174/187484490150201000110.2174/1874844901502010001 ↗
6. 10.1167/iovs.03-095910.1167/iovs.03-0959 ↗
7. 10.1097/OPX.000000000000080910.1097/OPX.0000000000000809 ↗
8. 10.1016/j.jconrel.2006.05.00310.1016/j.jconrel.2006.05.003 ↗
9. 10.1007/BF0031764610.1007/BF00317646 ↗
10. 10.1016/j.oftal.2019.07.00910.1016/j.oftal.2019.07.009 ↗
11. 10.1016/j.actbio.2018.11.02010.1016/j.actbio.2018.11.020 ↗
12. 10.1016/S1773-2247(07)50010-910.1016/S1773-2247(07)50010-9 ↗
13. 10.1097/ICO.000000000000172510.1097/ICO.0000000000001725 ↗
14. 10.1016/j.ijpharm.2004.11.03310.1016/j.ijpharm.2004.11.033 ↗
15. 10.1002/adhm.20180139010.1002/adhm.201801390 ↗
16. Kurniawansyah I. S. · J. Pharm. Sci. Res. · 2018 · 10 · 254
17. 10.3390/molecules2403060310.3390/molecules24030603 ↗
18. 10.1002/pola.2360710.1002/pola.23607 ↗
19. 10.1016/j.biomaterials.2019.11928510.1016/j.biomaterials.2019.119285 ↗
20. 10.1016/j.jconrel.2007.09.00610.1016/j.jconrel.2007.09.006 ↗
21. 10.2165/00137696-200604030-0000210.2165/00137696-200604030-00002 ↗
22. 10.1038/185117a010.1038/185117a0 ↗
23. 10.1177/08853282930080020210.1177/088532829300800202 ↗
24. 10.1016/j.jconrel.2019.05.02510.1016/j.jconrel.2019.05.025 ↗
25. 10.1016/j.ejpb.2018.04.01710.1016/j.ejpb.2018.04.017 ↗
26. 10.1007/s13233-017-5068-y10.1007/s13233-017-5068-y ↗
27. 10.1163/092050611X56906010.1163/092050611X569060 ↗
28. 10.1002/app.4565410.1002/app.45654 ↗
29. 10.1039/C8BM00586A10.1039/C8BM00586A ↗
30. 10.1016/j.colsurfb.2010.01.02510.1016/j.colsurfb.2010.01.025 ↗
31. 10.1179/1753555712Y.000000004710.1179/1753555712Y.0000000047 ↗
32. 10.1080/09205063.2013.83091410.1080/09205063.2013.830914 ↗
33. 10.1016/j.polymer.2006.03.09610.1016/j.polymer.2006.03.096 ↗
34. 10.1007/s10965-012-9822-810.1007/s10965-012-9822-8 ↗
35. 10.1039/C9RA02858G10.1039/C9RA02858G ↗
36. 10.1080/0882053090280216110.1080/08820530902802161 ↗
37. 10.1016/j.ijpharm.2016.10.04710.1016/j.ijpharm.2016.10.047 ↗
38. 10.1097/ICL.0b013e31827cb99f10.1097/ICL.0b013e31827cb99f ↗
39. 10.1111/cxo.1259210.1111/cxo.12592 ↗
40. 10.1016/j.colsurfb.2020.11085910.1016/j.colsurfb.2020.110859 ↗
41. Yang X. · Int. J. Polym. Sci. · 2016 · 2016 · 4374060
42. 10.1021/acs.biomac.5b0138710.1021/acs.biomac.5b01387 ↗
43. 10.1080/10601325.2019.170080310.1080/10601325.2019.1700803 ↗
44. 10.1080/09205063.2017.136312710.1080/09205063.2017.1363127 ↗
45. 10.1002/app.4862210.1002/app.48622 ↗
46. 10.1016/j.ejpb.2020.07.03310.1016/j.ejpb.2020.07.033 ↗
47. 10.1016/j.biomaterials.2013.09.10910.1016/j.biomaterials.2013.09.109 ↗
48. 10.1016/j.jconrel.2016.08.02510.1016/j.jconrel.2016.08.025 ↗
49. 10.1080/10837450.2016.123013110.1080/10837450.2016.1230131 ↗
50. 10.1002/mabi.20050006510.1002/mabi.200500065 ↗
51. 10.1097/OPX.000000000000084910.1097/OPX.0000000000000849 ↗
52. 10.1016/j.jcis.2016.02.03710.1016/j.jcis.2016.02.037 ↗
53. 10.1088/1748-6041/8/5/05500710.1088/1748-6041/8/5/055007 ↗
54. 10.1016/j.ijpharm.2017.03.08210.1016/j.ijpharm.2017.03.082 ↗
55. 10.3109/02713683.2015.112372610.3109/02713683.2015.1123726 ↗
56. 10.1016/j.jconrel.2016.02.01210.1016/j.jconrel.2016.02.012 ↗
57. 10.1007/s13726-019-00758-810.1007/s13726-019-00758-8 ↗
58. 10.1016/j.memsci.2011.08.03010.1016/j.memsci.2011.08.030 ↗
59. 10.1016/j.jddst.2020.10179210.1016/j.jddst.2020.101792 ↗
60. 10.1007/s10965-019-1813-610.1007/s10965-019-1813-6 ↗
61. 10.1177/088532821558150710.1177/0885328215581507 ↗
62. 10.1021/acsami.8b0975510.1021/acsami.8b09755 ↗
63. 10.1021/am503940p10.1021/am503940p ↗
64. 10.1097/OPX.000000000000128210.1097/OPX.0000000000001282 ↗
65. 10.1016/j.colsurfb.2017.11.02110.1016/j.colsurfb.2017.11.021 ↗
66. 10.3390/polym1209208710.3390/polym12092087 ↗
67. 10.1177/088532821141099910.1177/0885328211410999 ↗
68. 10.1016/j.ijpharm.2018.04.00410.1016/j.ijpharm.2018.04.004 ↗
69. 10.1016/j.actbio.2015.08.01110.1016/j.actbio.2015.08.011 ↗
70. 10.1007/s13233-019-7050-310.1007/s13233-019-7050-3 ↗
71. 10.1016/j.jddst.2016.06.01610.1016/j.jddst.2016.06.016 ↗
72. 10.1167/iovs.08-282610.1167/iovs.08-2826 ↗
73. 10.1016/j.ijpharm.2020.11950610.1016/j.ijpharm.2020.119506 ↗
74. 10.1016/j.ijpharm.2018.10.04110.1016/j.ijpharm.2018.10.041 ↗
75. 10.1016/j.colsurfb.2016.07.04710.1016/j.colsurfb.2016.07.047 ↗
76. 10.1016/j.msec.2018.07.06510.1016/j.msec.2018.07.065 ↗
77. 10.3390/polym1106094410.3390/polym11060944 ↗
78. 10.1039/C8BM00212F10.1039/C8BM00212F ↗
79. 10.1016/j.ajps.2018.05.00210.1016/j.ajps.2018.05.002 ↗
80. 10.1039/C9TB00949C10.1039/C9TB00949C ↗
81. 10.1016/j.progpolymsci.2018.06.00110.1016/j.progpolymsci.2018.06.001 ↗
82. 10.1080/09205063.2013.84022810.1080/09205063.2013.840228 ↗
83. 10.1039/C7RA12753G10.1039/C7RA12753G ↗
84. 10.3109/10717544.2010.52261210.3109/10717544.2010.522612 ↗
85. 10.1109/JMEMS.2019.292723210.1109/JMEMS.2019.2927232 ↗
86. 10.1021/acsami.0c0684710.1021/acsami.0c06847 ↗
87. 10.1186/s40486-019-0101-x10.1186/s40486-019-0101-x ↗